XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
171 hedge funds and large institutions have $2.3B invested in Acceleron Pharma in 2019 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 74 increasing their positions, 45 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
6% more funds holding
Funds holding: 162 → 171 (+9)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
171
Holding in Top 10
3
Calls
$17.5M
Puts
$15.2M
Top Buyers
| 1 | +$68.4M | |
| 2 | +$27.9M | |
| 3 | +$22.8M | |
| 4 |
Alkeon Capital Management
New York
|
+$21.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$20.3M |
Top Sellers
| 1 | -$39.9M | |
| 2 | -$24.2M | |
| 3 | -$15.2M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$11.5M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$10.3M |